A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.

Stopped early · Phase 2

Conditions studied: Osteoporosis

In brief

This is a 12 month study designed to evaluate the safety and effectiveness of SB-751689 in the treatment of osteoporosis in post-menopausal women, in comparison with 2 active comparators and placebo.

Key facts

Study ID

NCT00471237

Run by

GlaxoSmithKline

People needed

564

Starts

2007-05-14

Expected to finish

2008-12-26

Last updated by the study team

2017-11-07

Who can join

Age: 18 and older, up to 79. Sex: female. Healthy volunteers: not accepted.

Where it is running

• GSK Investigational Site — Oakland, California, United States
• GSK Investigational Site — Palm Desert, California, United States
• GSK Investigational Site — Walnut Creek, California, United States
• GSK Investigational Site — Decatur, Georgia, United States
• GSK Investigational Site — Bethesda, Maryland, United States
• GSK Investigational Site — Akron, Ohio, United States
• GSK Investigational Site — Cleveland, Ohio, United States
• GSK Investigational Site — Portland, Oregon, United States
• GSK Investigational Site — Duncansville, Pennsylvania, United States
• GSK Investigational Site — Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
• GSK Investigational Site — Buenos Aires, Argentina
• GSK Investigational Site — Buenos Aires, Argentina
• GSK Investigational Site — St Leonards, New South Wales, Australia
• GSK Investigational Site — Footscray, Victoria, Australia
• GSK Investigational Site — Geelong, Victoria, Australia
• GSK Investigational Site — Heidelberg, Victoria, Australia
• GSK Investigational Site — Ghent, Belgium
• GSK Investigational Site — Liège, Belgium
• GSK Investigational Site — Tienen, Belgium
• GSK Investigational Site — Ballerup Municipality, Denmark
• GSK Investigational Site — Frankfurt am Main, Hesse, Germany
• GSK Investigational Site — Berlin, Germany
• GSK Investigational Site — Berlin, Germany
• GSK Investigational Site — Berlin, Germany
• GSK Investigational Site — Berlin, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.